PIMTARGA Trademark

Trademark Overview

On Thursday, April 15, 2010, a trademark application was filed for PIMTARGA with the United States Patent and Trademark Office. The USPTO has given the PIMTARGA trademark a serial number of 85014638. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 20, 2014. This trademark is owned by Glaxo Group Limited. The PIMTARGA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
pimtarga

General Information

Serial Number85014638
Word MarkPIMTARGA
Filing DateThursday, April 15, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 20, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 19, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 21, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGLAXOSMITHKLINE LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressWILMINGTON, COUNTY OF NEW CASTLE, DE 19808
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Tuesday, January 21, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 20, 2014ABANDONMENT - NO USE STATEMENT FILED
Friday, June 7, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 7, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 4, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 3, 2013EXTENSION 5 GRANTED
Thursday, May 23, 2013EXTENSION 5 FILED
Thursday, May 23, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 25, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 21, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 21, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 25, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 24, 2012EXTENSION 4 GRANTED
Monday, October 22, 2012EXTENSION 4 FILED
Monday, October 22, 2012TEAS EXTENSION RECEIVED
Wednesday, July 18, 2012AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, May 25, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 24, 2012EXTENSION 3 GRANTED
Tuesday, May 22, 2012EXTENSION 3 FILED
Tuesday, May 22, 2012TEAS EXTENSION RECEIVED
Tuesday, November 29, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 28, 2011EXTENSION 2 GRANTED
Wednesday, November 23, 2011EXTENSION 2 FILED
Wednesday, November 23, 2011TEAS EXTENSION RECEIVED
Wednesday, June 15, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 14, 2011EXTENSION 1 GRANTED
Thursday, June 9, 2011EXTENSION 1 FILED
Tuesday, June 14, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 9, 2011TEAS EXTENSION RECEIVED
Tuesday, December 14, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 19, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 19, 2010PUBLISHED FOR OPPOSITION
Friday, September 10, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 10, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 10, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 10, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 10, 2010ASSIGNED TO LIE
Monday, August 23, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 23, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 14, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 14, 2010NON-FINAL ACTION E-MAILED
Wednesday, July 14, 2010NON-FINAL ACTION WRITTEN
Tuesday, July 13, 2010ASSIGNED TO EXAMINER
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 21, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 19, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

pimtarga pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic